USE OF ERIBULIN AND MTOR INHIBITORS AS COMBINATION THERAPY FOR THE TREATMENT OF CANCER

• 收藏
• 分享

专利权人:

发明人:

LITTLEFIELD BRUCE A

申请号：

IN201647032920

公开号：

IN201647032920A

申请日:

2016.09.27

申请国别(地区):

IN

年份:

2016

代理人:

摘要：

Methods for treating cancer (e.g. breast cancer lung cancer pancreatic cancer primitive neuroectodermal tumors lung cancer ovaria cancer endometrial cancer pharyngeal cancer esophageal cancer and sarcoma) in a subject (such as an human patient) in need thereof by administering eribulin (e.g. eribulin mesylate i.e. E7389 Halaven) in combination with one or more mammalian target of rapamycin (mTOR) inhibitors (e.g. everolimus ridaforolimus and temsirolimus) and kits therefor are provided.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/